|
Joseph
|
Joseph Edelman: CEO, Perceptive Advisors, LLCNew York, New YorkA renowned biotechnology market analyst, Joseph Edelman maintains a rigorous skepticism that has functioned as an integral resource in building a prosperous career of financially supporting the development of life science innovations. As the founder and Chief Executive Officer of Perceptive Advisors LLC, he examines long- and short-term biotech investment proposals to determine the validity and potential of emerging treatments and technologies. His questioning nature has become a cornerstone in the company’s core principle: to obtain a rivaling advantage by recognizing when the market’s presumption of a specific company has detoured from reality. Under the adherence of this business ideal, Joseph Edelman has produced remarkable results for Perceptive Advisors. As of May 2011, he has transformed Perceptive Advisors into a flourishing corporation with assets totaling more than $400 million. Prior to creating Perceptive Advisors in 1999, Joseph Edelman maintained a prominent career in the biotechnology analysis industry. After obtaining a Master of Business Administration from the Leonard N. Stern School of Business at New York University, he accepted a position with small-scale brokerage firm Labe, Simpson & Co. where he functioned as a Biotechnology Analyst and composed numerous diagnostic reports. It was not until Joseph Edelman’s analysis of Cambridge Bioscience Limited, an evaluation of a five-minute AIDS test, that his hard-lining assessments became widely recognized and applauded. After publishing his profound analytics report, Joseph Edelman was offered a Senior Biotechnology Analyst position with Prudential Securities. Before establishing his own investment firm, he was also employed by Paramount Capital Asset Management, Inc., where he also served as a Senior Analyst. Joseph Edelman's Schools
Joseph Edelman's Companies
Joseph Edelman's Publications
|
